Creating A Risk assessment biomarker tool to prevent Seasonal and Thunderstorm Asthma – CARISTA Study (NCT07055542)

CARISTA will test a new approach to predict risk for seasonal allergic asthma to identify treatable traits for preventing seasonal allergic asthma exacerbations to reduce the recurrent annual health threat of seasonal and thunderstorm asthma, address community and health care provider concerns and uncertainty regarding preventive treatment and management.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof Mark Hew

Key inclusion data

Aged between 18-70yrs; Those deemed at high risk of seasonal allergic asthma and thunderstorm asthma will be eligible; Able to carry out lung function testing; Severe asthmatics and those with unstable asthma are excluded; The presence of any medical illness, such as cardiac disease, pre-existing illness or immunomodulatory therapy that, in the opinion of the Investigators, would compromise participant safety or the derivation of biomarkers during the study will be excluded